EC
JANX icon

EcoR1 Capital’s Janux Therapeutics JANX Stock Holding History

EcoR1 Capital’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,469,818
Closed -$34M – 36
2025
Q2 		$34M Hold
1,469,818
– – 2.01% 12
2025
Q1 		$39.7M Hold
1,469,818
– – 2.36% 11
2024
Q4 		$78.7M Hold
1,469,818
– – 3.14% 11
2024
Q3 		$66.8M Hold
1,469,818
– – 2.29% 11
2024
Q2 		$61.6M Buy
+1,469,818
New +$69M 1.88% 15
2023
Q3 		– Sell
-452,590
Closed -$5.37M – 55
2023
Q2 		$5.37M Sell
452,590
-3,385,896
-88% -$45.3M 0.14% 38
2023
Q1 		$46.4M Buy
3,838,486
+2,417,167
+170% +$40.2M 1.5% 15
2022
Q4 		$18.7M Hold
1,421,319
– – 0.57% 30
2022
Q3 		$19.2M Hold
1,421,319
– – 0.57% 28
2022
Q2 		$17.4M Hold
1,421,319
– – 0.6% 30
2022
Q1 		$20.4M Buy
1,421,319
+9,344
+0.7% +$153K 0.64% 30
2021
Q4 		$27.9M Hold
1,411,975
– – 0.89% 23
2021
Q3 		$30.5M Hold
1,411,975
– – 1.07% 18
2021
Q2 		$35.2M Buy
+1,411,975
New +$31.4M 1.32% 16

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return